Icu Medical Stock Performance
| ICUI Stock | USD 152.67 5.87 3.70% |
On a scale of 0 to 100, ICU Medical holds a performance score of 14. The firm retains a Market Volatility (i.e., Beta) of 1.06, which attests to a somewhat significant risk relative to the market. ICU Medical returns are very sensitive to returns on the market. As the market goes up or down, ICU Medical is expected to follow. Please check ICU Medical's potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether ICU Medical's current trending patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ICU Medical are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, ICU Medical demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (3.70) | Five Day Return (1.02) | Year To Date Return 10.21 | Ten Year Return 62.36 | All Time Return 3.2 K |
Last Split Factor 3:2 | Last Split Date 2002-03-18 |
1 | Disposition of 430 shares by Ben Sousa of ICU Medical subject to Rule 16b-3 | 10/31/2025 |
2 | ICU Medicals Q3 Strong Sales | 11/06/2025 |
3 | Disposition of 930 shares by Virginia Sanzone of ICU Medical at 142.345 subject to Rule 16b-3 | 11/11/2025 |
4 | ICU Medical Is Up 6.8 percent After Narrowing 2025 Net Loss Guidance Has Operational Discipline Peaked | 11/14/2025 |
5 | How New Portfolio Moves Are Shaping the Narrative for ICU Medical | 12/03/2025 |
6 | How Slowing Sales and Cash Strain Could Impact ICU Medicals Investment Story | 12/17/2025 |
7 | Is Weakening Demand And Falling Sales Outlook Altering The Investment Case For ICU Medical | 12/23/2025 |
8 | Opportunities and Competition in the 1.19 Billion U.S. IV Bags Market, 2025-2033, Featuring Baxter International, Kraton, Technoflex, B. Braun Medical, Sippex I... | 12/29/2025 |
9 | Intravenous Solutions Market Size to Reach USD 25.10 Billion by 2033, Growing at a CAGR of 8.24 percent - SNS Insider | 01/09/2026 |
10 | ICU Medical, Inc. ICUI Shares Sold by Nisa Investment Advisors LLC | 01/16/2026 |
11 | Trends Strategies Shaping the 1,357.40 Million Elastomeric Infusion Pumps Market, 2025-2033 Astute Analytica | 01/20/2026 |
| Begin Period Cash Flow | 254.2 M | |
| Total Cashflows From Investing Activities | -89 M |
ICU Medical Relative Risk vs. Return Landscape
If you would invest 12,011 in ICU Medical on October 28, 2025 and sell it today you would earn a total of 3,256 from holding ICU Medical or generate 27.11% return on investment over 90 days. ICU Medical is currently generating 0.4111% in daily expected returns and assumes 2.203% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than ICU, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ICU Medical Target Price Odds to finish over Current Price
The tendency of ICU Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 152.67 | 90 days | 152.67 | about 14.64 |
Based on a normal probability distribution, the odds of ICU Medical to move above the current price in 90 days from now is about 14.64 (This ICU Medical probability density function shows the probability of ICU Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.06 . This usually indicates ICU Medical market returns are responsive to returns on the market. As the market goes up or down, ICU Medical is expected to follow. Additionally ICU Medical has an alpha of 0.3408, implying that it can generate a 0.34 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). ICU Medical Price Density |
| Price |
Predictive Modules for ICU Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ICU Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ICU Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ICU Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ICU Medical is not an exception. The market had few large corrections towards the ICU Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ICU Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ICU Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.34 | |
β | Beta against Dow Jones | 1.06 | |
σ | Overall volatility | 11.17 | |
Ir | Information ratio | 0.16 |
ICU Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ICU Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ICU Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 2.38 B. Net Loss for the year was (117.69 M) with profit before overhead, payroll, taxes, and interest of 846.31 M. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Trends Strategies Shaping the 1,357.40 Million Elastomeric Infusion Pumps Market, 2025-2033 Astute Analytica |
ICU Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ICU Stock often depends not only on the future outlook of the current and potential ICU Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ICU Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 24.4 M | |
| Cash And Short Term Investments | 308.6 M |
ICU Medical Fundamentals Growth
ICU Stock prices reflect investors' perceptions of the future prospects and financial health of ICU Medical, and ICU Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ICU Stock performance.
| Return On Equity | -0.0035 | ||||
| Return On Asset | 0.0192 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 4.83 B | ||||
| Shares Outstanding | 24.69 M | ||||
| Price To Earning | 38.71 X | ||||
| Price To Book | 1.77 X | ||||
| Price To Sales | 1.62 X | ||||
| Revenue | 2.38 B | ||||
| Gross Profit | 846.31 M | ||||
| EBITDA | 42.96 M | ||||
| Net Income | (117.69 M) | ||||
| Cash And Equivalents | 285.59 M | ||||
| Cash Per Share | 11.95 X | ||||
| Total Debt | 1.64 B | ||||
| Debt To Equity | 0.84 % | ||||
| Current Ratio | 2.45 X | ||||
| Book Value Per Share | 86.17 X | ||||
| Cash Flow From Operations | 204.03 M | ||||
| Earnings Per Share | (0.32) X | ||||
| Market Capitalization | 3.77 B | ||||
| Total Asset | 4.2 B | ||||
| Retained Earnings | 690.16 M | ||||
| Working Capital | 885.8 M | ||||
| Current Asset | 505.01 M | ||||
| Current Liabilities | 42.62 M | ||||
About ICU Medical Performance
By evaluating ICU Medical's fundamental ratios, stakeholders can gain valuable insights into ICU Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ICU Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ICU Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 123.34 | 72.68 | |
| Return On Tangible Assets | (0.07) | (0.06) | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | (0.07) | (0.07) |
Things to note about ICU Medical performance evaluation
Checking the ongoing alerts about ICU Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ICU Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 2.38 B. Net Loss for the year was (117.69 M) with profit before overhead, payroll, taxes, and interest of 846.31 M. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Trends Strategies Shaping the 1,357.40 Million Elastomeric Infusion Pumps Market, 2025-2033 Astute Analytica |
- Analyzing ICU Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ICU Medical's stock is overvalued or undervalued compared to its peers.
- Examining ICU Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ICU Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ICU Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ICU Medical's stock. These opinions can provide insight into ICU Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |